Information for Contraindications of incretin therapy
Page information·measured at build time
Technical and provenance information about Contraindications of incretin therapy. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Contraindications of incretin therapy |
|---|---|
| Default sort key | Contraindications of incretin therapy |
| Namespace | Article (main) |
| Page kind | Concept |
| Page length (source, bytes) | 4,993 |
| Rendered word count | 573 |
| Internal wiki links on the page | 16 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — concept |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | Peptide_Pete |
|---|---|
| Date of page creation | 1 November 2024 |
| Latest editor | CategoryBot |
| Date of latest edit | 19 July 2026 |
| Total number of edits | 28 |
| Total number of distinct authors | 23 |
| Minor edits | 13 |
| Automated (bot) edits | 6 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 4 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| Chromatokid | 3 | 10.7% | analytical chemistry and chromatography |
| NAION_Noel | 2 | 7.1% | adverse effects and clinical safety |
| ArchiveBot | 2 | 7.1% | policy, notability and deletion |
| CiteBot | 2 | 7.1% | copy-editing and the manual of style |
| Peptide_Pete | 1 | 3.6% | research peptides |
| ClinicCorrespondent | 1 | 3.6% | adverse effects and clinical safety |
| SiteReactionSuz | 1 | 3.6% | adverse effects and clinical safety |
| NauseaNoor | 1 | 3.6% | adverse effects and clinical safety |
| PuffRemoverPax | 1 | 3.6% | policy, notability and deletion |
| ResinRhoswen | 1 | 3.6% | peptide synthesis and supply chain |
| INN_Ingrid | 1 | 3.6% | GLP-1 receptor agonists and related compounds |
| HypoHildur | 1 | 3.6% | adverse effects and clinical safety |
Category membership
- Category:Contraindications and cautions — 1 member pages
- Category:Clinical practice — 23 member pages
- Category:Adverse effects — 8 member pages